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Background
To distinguish HIV-1 patients with clinical diversity by
using a simplified model of T-cell interactions
Methods
During 28 months, 1074 blood samples from 200 HIV-1
patients and 418 blood samples from healthy blood
donors were prospectively collected. T lymphocyte sub-
sets and activation markers expression (CD4, CD69,
CD25, CD8, CD28, HLA-DR) were determined initially
and after PHA stimulation in whole blood cultures.
Results
Two step Cluster Analysis followed by a discriminant
function analysis of the lymphocyte activation assay
from the first blood sample, allowed the separation of
HIV-1 patients in two groups: Cluster1 (67%) and Clus-
ter2 (33%). Clusters definition relied on the level of
three T-cells subsets: a) stimulated CD4
+CD69
+CD25
high, b) unstimulated CD4
+CD69
+CD25
+ and c)
unstimulated CD4
+CD25
high. PHA stimulated CD4
+CD69
+ CD25
high subset level alone allowed to classify
correctly patients with 92% sensitivity and 87% specifi-
city. Cluster-2 expressed more CD69 and HLA-DR acti-
vation markers on CD4 and CD8 lymphocytes, less CD8
+CD28
+ and responded less to mitogen even if viral load
undetectable. Cluster-2 presented poorly clinical profile
in terms of previous AIDS events, current CD4
+ count,
viral load, length of treatment. Over the time most
patients (64%) were keeping their cluster category.
Discussion
We propose an algorithm to identify a subset of HIV
patients with an over-determined immunodeficiency sta-
tus characterized by a lower ability to reverse
inappropriate activation of CD4 and CD8 T-lymphocytes
leading probably to earlier exhaustion of their immunolo-
gical resources. This subgroup of patients could display a
worst clinical evolution, lower control capacity of viral
load, even under antiretroviral therapy-mediated viral
suppression.
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